1. Home
  2. COGT vs LW Comparison

COGT vs LW Comparison

Compare COGT & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$37.08

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Lamb Weston Holdings Inc.

LW

Lamb Weston Holdings Inc.

HOLD

Current Price

$46.38

Market Cap

7.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
COGT
LW
Founded
2014
1950
Country
United States
United States
Employees
N/A
10100
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.0B
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
COGT
LW
Price
$37.08
$46.38
Analyst Decision
Buy
Buy
Analyst Count
15
7
Target Price
$33.50
$56.14
AVG Volume (30 Days)
1.4M
1.6M
Earning Date
05-22-2026
03-19-2026
Dividend Yield
N/A
3.33%
EPS Growth
N/A
N/A
EPS
N/A
0.90
Revenue
$7,871,000.00
N/A
Revenue This Year
N/A
$4.23
Revenue Next Year
$1,180.55
N/A
P/E Ratio
N/A
$50.89
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$39.79
52 Week High
$43.73
$67.07

Technical Indicators

Market Signals
Indicator
COGT
LW
Relative Strength Index (RSI) 46.31 44.36
Support Level $36.52 $41.41
Resistance Level $41.02 $57.57
Average True Range (ATR) 1.86 1.45
MACD -0.15 -0.34
Stochastic Oscillator 30.69 24.55

Price Performance

Historical Comparison
COGT
LW

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About LW Lamb Weston Holdings Inc.

Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by french fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single-largest customer at 15% of fiscal 2025 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.

Share on Social Networks: